Pfizer, BioNTech apply for emergency use authorization of COVID-19 vaccine
Pfizer and its German partner BioNTech formally submitted their request Nov. 20 for emergency use authorization of a COVID-19 vaccine.
Pfizer and its German partner BioNTech formally submitted their request Nov. 20 for emergency use authorization of a COVID-19 vaccine.